Hypothyroidism is the most common endocrinopathy and occurs in higher incidence with anti-PD-1/PD-L1 agents in HNSCC patients (6.8–16%), and the majority of cases are with mild symptoms. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.